Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients

Immunosuppression can lead to hepatitis B virus (HBV) reactivation in hepatitis B core antigen antibodies (anti-HBc) positive patients, especially those undergoing chemotherapy, although there is limited data on solid organ recipients, especially lung transplantation. Our aim was to analyze the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-López, Patricia, Riveiro-Barciela, Mar, Oleas-Vega, Diana, Flores-Cortes, Claudia, Román, Antonio, Perelló, Manel, Berastegui, Cristina, Castells, Lluis, Esteban, Rafael, Buti, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478413/
https://www.ncbi.nlm.nih.gov/pubmed/32118794
http://dx.doi.org/10.1097/MD.0000000000019407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478413/
https://www.ncbi.nlm.nih.gov/pubmed/32118794
http://dx.doi.org/10.1097/MD.0000000000019407

Ejemplares similares